We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ABR icon
351
Arbor Realty Trust
ABR
$528M
$1.43M 0.03%
124,176
-313,674
-72% -$4.35M
2020 Q3
10 quarters
CTLT icon
352
DELISTED
CATALENT, INC.
CTLT
$1.42M 0.03%
21,576
-2,173
-9% -$134K
2022 Q3
2 quarters
NBR icon
353
PUT
Nabors Industries
NBR
$1.2B
$1.41M 0.03%
+41,900
New +$6.35M
2023 Q1
0 quarters
SPWR icon
354
SunPower Inc
SPWR
$55.5M
$1.41M 0.03%
136,747
– –
2021 Q2
7 quarters
AUTL icon
355
Autolus Therapeutics
AUTL
$466M
$1.39M 0.03%
757,008
+36,048
+5% +$70.5K
2022 Q1
4 quarters
AXSM icon
356
Axsome Therapeutics
AXSM
$8.69B
$1.39M 0.03%
22,566
+12,075
+115% +$793K
2022 Q1
4 quarters
ATVI
357
CALL
DELISTED
Activision Blizzard
ATVI
$1.37M 0.03%
+533,700
New +$41.5M
2023 Q1
0 quarters
ICLR icon
358
Icon
ICLR
$12.7B
$1.35M 0.03%
6,318
-699
-10% -$156K
2022 Q2
3 quarters
HLVX icon
359
DELISTED
HilleVax
HLVX
$1.34M 0.03%
81,267
+1,900
+2% +$30.4K
2022 Q2
3 quarters
TWLO icon
360
Twilio
TWLO
$43.4B
$1.33M 0.03%
+20,000
New +$1.23M
2023 Q1
0 quarters
LTC icon
361
LTC Properties
LTC
$2.32B
$1.26M 0.03%
+35,776
New +$1.29M
2023 Q1
0 quarters
EPR icon
362
EPR Properties
EPR
$4.25B
$1.24M 0.03%
32,656
+7,062
+28% +$281K
2021 Q4
5 quarters
ALB icon
363
Albemarle
ALB
$11.6B
$1.24M 0.03%
5,616
-430
-7% -$106K
2022 Q4
1 quarter
TRIS icon
364
DELISTED
Tristar Acquisition I Corp.
TRIS
$1.23M 0.03%
119,545
– –
2021 Q4
5 quarters
TARS icon
365
Tarsus Pharmaceuticals
TARS
$3.48B
$1.23M 0.03%
98,175
+4,675
+5% +$68.4K
2022 Q3
2 quarters
AGIO icon
366
Agios Pharmaceuticals
AGIO
$1.84B
$1.21M 0.03%
52,500
+2,500
+5% +$66.4K
2022 Q4
1 quarter
ROIV icon
367
Roivant Sciences
ROIV
$25B
$1.19M 0.03%
161,825
+19,325
+14% +$159K
2022 Q4
1 quarter
PRCT icon
368
Procept Biorobotics
PRCT
$1.12B
$1.19M 0.03%
41,943
+30,069
+253% +$1.06M
2022 Q4
1 quarter
MORF icon
369
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.15M 0.03%
30,552
-12,831
-30% -$473K
2022 Q1
4 quarters
AKR icon
370
Acadia Realty Trust
AKR
$2.52B
$1.15M 0.03%
+82,368
New +$1.19M
2023 Q1
0 quarters
ZM icon
371
Zoom
ZM
$28.6B
$1.11M 0.03%
+15,000
New +$1.08M
2023 Q1
0 quarters
VKTX icon
372
Viking Therapeutics
VKTX
$3.6B
$1.09M 0.03%
65,608
-118,304
-64% -$1.22M
2022 Q3
2 quarters
SVRA icon
373
Savara
SVRA
$992M
$1.09M 0.03%
556,513
+105,072
+23% +$237K
2022 Q2
3 quarters
SRRK icon
374
Scholar Rock
SRRK
$5.11B
$1.08M 0.03%
135,556
+6,455
+5% +$65.5K
2022 Q2
3 quarters
OFIX icon
375
Orthofix Medical
OFIX
$378M
$1.08M 0.03%
+64,680
New +$1.27M
2023 Q1
0 quarters

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.